Ralovera
Ralovera Brand names, Ralovera Analogs
- Amen
- Aragest
- Aragest 5
- Asconale
- Clinofem
- Clinovir
- Colirest
- Crinone
- Curretab
- Cycrin
- DMPA
- Depo-Clinovir
- Depo-Prodasone
- Depo-Progestin
- Depo-Promone
- Depo-Provera
- Depo-Subq Provera 104
- Depomedroxyprogesterone acetate
- Depot-Medroxyprogesterone acetate
- Farlutal
- Farlutin
- G-Farlutal
- Gestapuran
- Hematrol
- Hydroxymethylprogesterone
- Hysron
- Indivina
- Lunelle
- Lutopolar
- Lutoral
- MAP
- MPA
- Med-Pro
- Medroprogesterone Acetate
- Medrossiprogesterone [Dcit]
- Medroxiprogesterona [Inn-Spanish]
- Medroxiprogesteronum
- Medroxyprogesteron
- Medroxyprogesteron acetate
- Medroxyprogesterone acetate
- Medroxyprogesterone Base
- Medroxyprogesteronum [Inn-Latin]
- Meprate
- Metigestrona
- MPA Gyn 5
- Nadigest
- Nidaxin
- Novo-Medrone
- Oragest
- Perlutex
- Perlutex Leo
- Prempro/Premphase
- Prodasone
- Progestalfa
- Progestasert
- Progesterone
- Progeston
- Progevera
- Prometrium
- Provera
- Proverone
- Ralovera
- Repromap
- Repromix
- Sirprogen
- Sodelut G
- Veramix
Ralovera Brand Names Mixture
- Lunelle (Medroxyprogesterone + Estradiol)
Ralovera Chemical_Formula
C22H32O3
Ralovera RX_link
http://www.rxlist.com/cgi/generic/medrox.htm
Ralovera fda sheet
Ralovera msds (material safety sheet)
Ralovera Synthesis Reference
P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)
Ralovera Molecular Weight
344.488 g/mol
Ralovera Melting Point
220 - 223.5 oC
Ralovera H2O Solubility
22.2mg/L
Ralovera State
Solid
Ralovera LogP
3.606
Ralovera Dosage Forms
Tablets; Depo injection
Ralovera Indication
Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.
Ralovera Pharmacology
Medroxyprogesterone is a synthetic progestin more potent than progesterone.
Ralovera Absorption
Rapidly absorbed from GI tract
Ralovera side effects and Toxicity
Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.
Ralovera Patient Information
Ralovera Organisms Affected
Humans and other mammals
